Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Return on Invested Capital (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Return on Invested Capital for 4 consecutive years, with 3.0% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Invested Capital fell 44.0% to 3.0% in Q3 2025 year-over-year; TTM through Sep 2025 was 3.0%, a 44.0% decrease, with the full-year FY2024 number at 1.89%, down 97.0% from a year prior.
  • Return on Invested Capital was 3.0% for Q3 2025 at bioAffinity Technologies, down from 39.37% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 39.37% in Q2 2025 to a low of 3.95% in Q1 2025.
  • A 4-year average of 1.68% and a median of 1.35% in 2023 define the central range for Return on Invested Capital.
  • Biggest YoY gain for Return on Invested Capital was 4137bps in 2025; the steepest drop was -247bps in 2025.
  • bioAffinity Technologies' Return on Invested Capital stood at 0.24% in 2022, then crashed by -408bps to 1.23% in 2023, then crashed by -123bps to 2.73% in 2024, then decreased by -10bps to 3.0% in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Return on Invested Capital are 3.0% (Q3 2025), 39.37% (Q2 2025), and 3.95% (Q1 2025).